AxoGen Inc reports results for the quarter ended in September 30 - Earnings Summary

AxoGen

07/11/2024 14:32

* AxoGen Inc  AXGN.OQ  reported quarterly adjusted earnings
of 7
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 1 cents.  The mean expectation of six analysts for the
quarter was for earnings of one cent per share. Wall Street
expected results to range from -3 cents to 4 cents per share.
    * Revenue rose 17.9% to $48.64 million from a year ago;
analysts
expected $47.07 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 4
cents​.
    * The company reported a quarterly loss of $1.86 million.
    * AxoGen Inc shares had risen by 9.3% this quarter and
gained 124.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 333.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for AxoGen Inc is
$17.00 
This summary was machine generated from LSEG data November 7 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.01           0.07           Beat
 Jun. 30 2024      -0.04          0.05           Beat
 Mar. 31 2024      -0.07          -0.06          Beat
 Dec. 31 2023      -0.10          -0.06          Beat